FCRC Contract Will Be Completed In Five Parts, Two of Them For Small Business; RFP Available July 24
In Brief: Chabner Names DCT Acting Director, Schepartz Returns To Deputy Job; GM Winners Announced
DCT Board Approves Concepts Of Eight New Biological Response Modifiers Program
FDA Committee Oks AMSA for Group C List, Tables THC Request, Deadlocks On Estramustine NDA
NTP Panel Agrees PBB Carcinogenic, Two Asbestos Varieties Are Not
Trending Stories
- As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.” - Pancreatic cancer breakthrough came from smart scientists making smart bets—not from politicization of science
- House bill gives NCI $7.4 billion in FY 2027—$110 million above current budget
- NIH calls for comment on proposal to limit the number of RPGs per PI
- The story of daraxonrasib is the ultimate hero’s journey
A narrative curve with twists, turns, intrigue, drama—and a blow to a mighty foe









